Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT00913471Active Not Recruiting

Biomarkers for Pain in Spinal Cord Injury (SCI) Patients

Role: collaborator

NCT01328860Phase 1Terminated

Autologous Stem Cells for Spinal Cord Injury (SCI) in Children

Role: collaborator

NCT01700166Phase 1Withdrawn

Umbilical Cord Blood in the Treatment of Stroke in Children.

Role: collaborator

NCT00779324Not ApplicableCompleted

Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study

Role: collaborator

NCT03582228Not ApplicableCompleted

Bridging Recovery Allies in Virtual Environments

Role: collaborator

NCT00573976Completed

Study to Assess the Validity and Reliability of the Spinal Cord Independence Measure (SCIM III)

Role: collaborator

All 6 trials loaded